1. Home
  2. MRNS vs TAIT Comparison

MRNS vs TAIT Comparison

Compare MRNS & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNS
  • TAIT
  • Stock Information
  • Founded
  • MRNS 2003
  • TAIT 1989
  • Country
  • MRNS United States
  • TAIT United States
  • Employees
  • MRNS N/A
  • TAIT N/A
  • Industry
  • MRNS Biotechnology: Pharmaceutical Preparations
  • TAIT Electronic Components
  • Sector
  • MRNS Health Care
  • TAIT Technology
  • Exchange
  • MRNS Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • MRNS 19.0M
  • TAIT 17.2M
  • IPO Year
  • MRNS 2014
  • TAIT 1995
  • Fundamental
  • Price
  • MRNS $0.30
  • TAIT $2.80
  • Analyst Decision
  • MRNS Buy
  • TAIT
  • Analyst Count
  • MRNS 12
  • TAIT 0
  • Target Price
  • MRNS $4.28
  • TAIT N/A
  • AVG Volume (30 Days)
  • MRNS 6.6M
  • TAIT 11.0K
  • Earning Date
  • MRNS 11-12-2024
  • TAIT 11-26-2024
  • Dividend Yield
  • MRNS N/A
  • TAIT 7.18%
  • EPS Growth
  • MRNS N/A
  • TAIT N/A
  • EPS
  • MRNS N/A
  • TAIT 0.22
  • Revenue
  • MRNS $31,466,000.00
  • TAIT $4,343,000.00
  • Revenue This Year
  • MRNS $20.74
  • TAIT N/A
  • Revenue Next Year
  • MRNS $32.38
  • TAIT N/A
  • P/E Ratio
  • MRNS N/A
  • TAIT $12.48
  • Revenue Growth
  • MRNS 1.63
  • TAIT N/A
  • 52 Week Low
  • MRNS $0.26
  • TAIT $2.57
  • 52 Week High
  • MRNS $11.26
  • TAIT $3.61
  • Technical
  • Relative Strength Index (RSI)
  • MRNS 25.07
  • TAIT 55.96
  • Support Level
  • MRNS $0.29
  • TAIT $2.81
  • Resistance Level
  • MRNS $0.37
  • TAIT $3.00
  • Average True Range (ATR)
  • MRNS 0.04
  • TAIT 0.09
  • MACD
  • MRNS 0.02
  • TAIT 0.01
  • Stochastic Oscillator
  • MRNS 17.95
  • TAIT 40.00

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: